ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE

N/A

Manufactured by Method Pharmaceuticals

778 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE

ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Method Pharmaceuticals. The most commonly reported adverse reactions for ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE include BREAST CANCER FEMALE, BREAST CANCER, DRUG INEFFECTIVE, ANXIETY, DEPRESSION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE.

Top Adverse Reactions

BREAST CANCER FEMALE69 reports
BREAST CANCER47 reports
DRUG INEFFECTIVE25 reports
ANXIETY21 reports
DEPRESSION20 reports
FATIGUE20 reports
NAUSEA19 reports
ARTHRALGIA17 reports
HEADACHE17 reports
DIZZINESS15 reports
INSOMNIA15 reports
DYSPNOEA14 reports
MYALGIA12 reports
PAIN12 reports
BREAST CANCER METASTATIC11 reports
FALL11 reports
VOMITING11 reports
COUGH10 reports
FEELING ABNORMAL10 reports
OVARIAN CANCER10 reports
ASTHENIA9 reports
DIARRHOEA9 reports
MUSCLE SPASMS9 reports
ABDOMINAL DISTENSION8 reports
MALAISE8 reports
TREMOR8 reports
BLOOD PRESSURE INCREASED7 reports
OEDEMA PERIPHERAL7 reports
PAIN IN EXTREMITY7 reports
SUICIDAL IDEATION7 reports
WEIGHT DECREASED7 reports
ALOPECIA6 reports
AMNESIA6 reports
CEREBROVASCULAR ACCIDENT6 reports
CONSTIPATION6 reports
DRUG HYPERSENSITIVITY6 reports
HEART RATE INCREASED6 reports
HOT FLUSH6 reports
HYPOAESTHESIA6 reports
MIGRAINE6 reports
MUSCULAR WEAKNESS6 reports
NEUROPATHY PERIPHERAL6 reports
OFF LABEL USE6 reports
PHARMACEUTICAL PRODUCT COMPLAINT6 reports
RASH6 reports
ASTHMA5 reports
CHEST PAIN5 reports
CONDITION AGGRAVATED5 reports
DEHYDRATION5 reports
HYPOTENSION5 reports
INCORRECT DOSE ADMINISTERED5 reports
PALPITATIONS5 reports
PARAESTHESIA5 reports
PRURITUS5 reports
WEIGHT INCREASED5 reports
ABDOMINAL PAIN4 reports
ADVERSE DRUG REACTION4 reports
AGITATION4 reports
ANGER4 reports
ATRIAL FIBRILLATION4 reports
BACK PAIN4 reports
BONE PAIN4 reports
BREAST MASS4 reports
BURNING SENSATION4 reports
CHILLS4 reports
CONTUSION4 reports
DYSPEPSIA4 reports
GAIT DISTURBANCE4 reports
GASTROOESOPHAGEAL REFLUX DISEASE4 reports
HAEMOGLOBIN DECREASED4 reports
HYPERHIDROSIS4 reports
INJECTION SITE PAIN4 reports
INJURY4 reports
MYOCARDIAL INFARCTION4 reports
OESTROGEN RECEPTOR ASSAY POSITIVE4 reports
OVARIAN CANCER METASTATIC4 reports
OVERDOSE4 reports
PLEURAL EFFUSION4 reports
PNEUMONIA4 reports
PRODUCT DOSE OMISSION ISSUE4 reports
PRODUCT SUBSTITUTION ISSUE4 reports
RASH PRURITIC4 reports
SEXUAL DYSFUNCTION4 reports
SLEEP DISORDER4 reports
SOMNOLENCE4 reports
THINKING ABNORMAL4 reports
TOOTHACHE4 reports
UPPER RESPIRATORY TRACT INFECTION4 reports
URINARY TRACT INFECTION4 reports
URTICARIA4 reports
VERTIGO4 reports
VISION BLURRED4 reports
AGGRESSION3 reports
BALANCE DISORDER3 reports
BLOOD CHOLESTEROL INCREASED3 reports
BREAST CYST3 reports
CONTRAST MEDIA REACTION3 reports
COVID 193 reports
CRYING3 reports
DEAFNESS3 reports

Report Outcomes

Out of 364 classified reports for ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE:

Serious 75.0%Non-Serious 25.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female352 (98.9%)
Male4 (1.1%)

Reports by Age

Age 5714 reports
Age 5612 reports
Age 5911 reports
Age 5810 reports
Age 508 reports
Age 548 reports
Age 558 reports
Age 527 reports
Age 537 reports
Age 607 reports
Age 516 reports
Age 636 reports
Age 455 reports
Age 485 reports
Age 645 reports
Age 705 reports
Age 404 reports
Age 464 reports
Age 614 reports
Age 624 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE?

This profile reflects 778 FDA FAERS reports that mention ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE?

Frequently reported terms in FAERS include BREAST CANCER FEMALE, BREAST CANCER, DRUG INEFFECTIVE, ANXIETY, DEPRESSION, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE?

Labeling and FAERS entries often list Method Pharmaceuticals in connection with ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.